Business
Is upbeat COVID-vaccine news priced into the market? – MarketWatch
A growing list of vaccine candidates have rolled out in recent weeks, offering the world a potential exit from a global pandemic nightmare that has claimed some 1.4 million lives in less than a year. On Monday, Astrazeneca
AZN,
-1.08%
and the University of Oxford said their COVID-19 experimental vaccine candidate has shown 90% efficacy in preventing infection, in late-stage trials, helping the markets rally to start a holiday-shortened week.Mondays news marks the third straight time that the…
